Measurement of myocardial amyloid deposition in systemic amyloidosis: Insights from cardiovascular magnetic resonance imaging

Journal of Internal Medicine

Volumn 277, Issue 5, 2015, Pages 605-614

  Barison, A ^a,b   Aquaro, G D ^a   Pugliese, N R ^a   Cappelli, F ^c   Chiappino, S ^a   Vergaro, G ^a   Mirizzi, G ^a   Todiere, G ^a   Passino, C ^a,b   Masci, P G ^a   Perfetto, F ^c   Emdin, M ^a,b  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Amyloidosis; Biomarker; Cardiac hypertrophy; Cardiology; Radiology

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMYLOID; CREATININE; GADODIAMIDE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; TROPONIN; TROPONIN I; CONTRAST MEDIUM; GADOLINIUM;

ADULT; AGED; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; EXTRACELLULAR SPACE; FEMALE; GENE; GENE MUTATION; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE DIASTOLIC FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE BIOPSY; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE HYPERTROPHY; HEMATOCRIT; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPERTENSION; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; TTR GENE; CARDIOMYOPATHY; CASE CONTROL STUDY; DIAGNOSTIC USE; HEART MUSCLE; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY;

AGED; AMYLOID; AMYLOIDOSIS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES;

EID: 84926613038     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12324     Document Type: Article

References (18)

1. Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010; 52: 347-61.
2. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005; 79: 319-28.
3. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008; 10: 54.
4. Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis 2013; 8: 31.
5. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111: 186-93.
6. Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008; 51: 1022-30.
7. Austin BA, Tang WHW, Rodriguez ER, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2009; 2: 1369-77.
8. Sado D, Flett A, Banypersad S, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012; 98: 1436-41.
9. Milanesi M, Barison A, Positano V, et al. Modified cine inversion recovery pulse sequence for the quantification of myocardial T1 and gadolinium partition coefficient. J Magn Reson imaging 2013; 37: 109-18.
10. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 2012; 14: 63.
11. Gai N, Turkbey EB, Nazarian S, et al. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med 2011; 65: 1407-15.
12. Banypersad SM, Sado DM, Flett AS, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013; 6: 34-9.
13. Aquaro GD, Pugliese NR, Perfetto F, et al. Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis. Int J Cardiovasc Imaging 2014; 30: 1105-15.
14. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010; 122: 138-44.
15. Fontana M, White SK, Banypersad SM, et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 2012; 14: 88.
16. White SK, Sado DM, Fontana M, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 2013; 6: 955-62.
17. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010; 12: 69.
18. Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc 2012; 1: e000364.